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Background: Pre-operative myocardial !brosis and remodeling impact on outcomes after aortic valve replace-
ment (AVR). We aimed at investigating the prognostic impact of preoperative electrocardiographic (ECG)
markers of left ventricular (LV) myocardial damage, i.e. bundle branch block (BBB) and ECG strain pattern
after (surgical or transcatheter) AVR for severe aortic stenosis (AS).
Methods: Between April 2008 and October 2017, we explored consecutive patients referred to our Heart Valve
Clinic for !rst AVR for severe AS. Detailed pre-operative phenotyping and ECG analysis were performed. Patients
were followed-up after AVR for major cardiac events (ME), i.e. cardiovascular death, cardiac hospitalization for
acute heart failure and stroke.
Results: BBB and ECG strainwere respectively observed in 13.5 and 21% of the 1122 patients included. These ECG
markers identi!ed a subgroup of older patients, with higher NYHA class and more advanced myocardial disease
as detected by echocardiography, i.e. higher LVmass and lower LV ejection fraction, global longitudinal strain and
integrated backscatter, than patients without ECG strain or BBB. ME occurred in 212 (18.6%) patients during a
mean follow-up of 4.4 ± 1.5 years with higher incidence in case of ECG strain or BBB (HR 1.56, 95%CI
1.13–2.14, p = 0.006; HR 1.47, 95%CI 1.02–2.13, p = 0.04 respectively). The prognostic value of ECG strain
remained signi!cant after adjustment for age, diabetes and pre-operative LVEF.
Conclusions: Pre-operative ECG markers of myocardial damage identify a subgroup of AS patients at high risk of
post-AVR cardiovascular complications irrespective of other prognostic factors and should help the
multiparametric staging of cardiac damage to guide AVR.






valve replacement (AVR) is the only treatment that proved ef!cacy to
reducemorbi-mortality in symptomatic patients with severe aortic ste-
nosis (AS) [1,2]. Nevertheless, one third of the patients remains symp-
tomatic [3–5] or does not improve their functional capacities after
surgery [6,7]. This lack of improvement is believed to re"ect accumulat-
ing myocardial damage, secondary to the long-standing pressure over-
load. In AS, the chronic increased afterload is known to induce
compensatory left ventricular hypertrophy (LVH), to maintain normal
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wall stress and cardiac function, and progressive myocardial !brosis,
both associated with adverse outcomes after AVR [8–10]. Recent !nd-
ings regarding cardiac !brosis and imaging have not been translated
into daily practice since cardiac magnetic resonance imaging (MRI) is
hardly accessible and speckle-tracking strain in transthoracic echocardi-
ography (TTE) is not feasible in a substantial proportion of patients with
AS due to poor echogenicity or atrial !brillation. Unlike these imaging
modalities, electrocardiogram (ECG) is a reliable and widespread tool
to quickly assess the markers of a pathological myocardium. In line, a
particular electrographic pattern called ECG strain has been described
as a speci!c marker of mid-wall myocardial !brosis on late gadolinium
enhancement and T1 mapping cardiac MRI [11]. This pattern has been
associated with an increased risk of cardiovascular mortality and mor-
bidity in asymptomatic severe AS [11,12] and after isolated surgical
AVR [13]. The !fth of patients with severe AS and presenting pre-
operative intraventricular conduction abnormalities, i.e. left or right
bundle branch block (LBBB or RBBB), were excluded in studies explor-
ing the ECG strain pattern. To date, there is no large prospective study
exploring the long-term prognostic impact of ECG markers of myocar-
dial damage (i.e. intraventricular conduction abnormalities and ECG
strain) after surgical or transcatheter AVR for severe AS. We hypothe-
sized patients with pre-operative ECG markers of ventricular myocar-
dial damage to be at high risk of post-AVR cardiovascular
complications irrespective of other prognostic factors.
2. Methods
2.1. Study population and design
From April 2008 to October 2017, we prospectively studied consec-
utive patients with severe AS referred to our Heart Valve Clinic (CHU
Lille) for an AVR [14,15]. The operative technique (surgical or transcath-
eter) was based on current guidelines and left to the discretion of the
Heart Team. Patients with another signi!cant valvular disease, ventric-
ular paced rhythm, amedical history of previous cardiac surgery or con-
genital heart disease were excluded. Informed consent was obtained
from each patient and the study protocol conforms to the ethical guide-
lines of the 1975 Declaration of Helsinki.
2.2. Transthoracic echocardiography
A comprehensive pre-operative TTE including assessment of the aor-
tic valve, was performed before AVR according to current guidelines
[16] using state-of-the-art echocardiographic ultrasound systems
(Vivid 7, Vivid E9 or Vivid E95, GE Healthcare, Little Chalfont, UK).
From 2014, ultrasonic myocardial tissue characterization for the LV
was implemented in routine: 2D speckle-tracking with systolic defor-
mation analysis and integrated backscatter (IBS) were performed. IBS
was obtained by placing region of interest in the mid-myocardium of
anterior septum in parasternal long-axis view. IBS was then calibrated
by subtracting pericardial IBS intensity as previously descried. [17]
2.3. Electrocardiogram
A standard pre-operative 12-lead ECGwas recorded at 25mm/s and
1mV/cm for all participants. ECG interpretationwas performed and ad-
judicated by several observers (AC, SN, FP, FJ, SM, HR, SO, CS, MW, AC,
ALM, BB & DM) blinded to clinical and outcome data. LVH was de!ned
by a Romhilt-Estes score ! (5 points) or a Sokolow-Lyon index
N3.5 mV [18] and the ECG strain was de!ned as !0.1 mV concave
downsloping ST-segment depression with asymmetrical T-wave inver-
sion in the lateral leads (I, aVL, V5, V6) as previously described. [19]
Baseline conduction abnormalities (left bundle branch block (LBBB),
right bundle branch block (RBBB)) were also recorded and de!ned in
accordance with the American Heart Association recommendations
[20]. Our population was divided in 3 groups according to the following
ECG patterns: group 1 = no ECG strain pattern, group 2 = ECG strain
pattern, group 3 = baseline conduction abnormalities.
2.4. Follow-up
Patients were followed-up by direct patient interview and clinical
examination, telephone calls with the physicians, patients or next of
kin, or review of the autopsy records and death certi!cates. The follow-
ing cardiac major events (ME) were recorded: cardiovascular deaths,
cardiac hospitalizations for acute heart failure and stroke [21]. All-
cause mortality was also recorded. Any event was adjudicated by two
independent investigators blinded to the index clinical and echocardio-
graphic data.
2.5. Statistical analysis
Based on previous literature, we hypothesized that a third of AS pa-
tients would display hallmark of cardiac damage, a rate of ME at 5 years
of 25% in patients without ECG strain and a rate of 35% in patients with
hallmark ofmyocardial damage/!brosis [8–22]. This hypothesis implied
that we had to analyse outcomes in at least 918 patients to obtain a sta-
tistical power of 90% and a probability of a type I error of 0.05 as previ-
ously described [23]. Continuous variables were tested for normality
with Shapiro test, and were given as mean ± SD. Categorical variables
were given as percentages of individuals. Patients were separated in
three groups according to pre-operative ECG patterns. One-way
ANOVA analysis of variance was used for comparison of the three
A. Global longitudinal strain according to pre-operative ECG 
B. Integrated backscatter according to pre-operative ECG 
Fig. 1.Ultrasonic myocardial characterization. Comparison of A. Global longitudinal strain
andB. Integratedbackscatter according to pre-operative ECG in thepatients included since
2014. p-Value by post-hoc t-test with Bonferroni correction. Mean ± SD. A. Global
longitudinal strain according to pre-operative ECG. B. Integrated backscatter according
to pre-operative ECG.
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groups with Bonferroni post hoc t-test. Time-related clinical events
were plotted with Kaplan-Meier curves according to ECG strain and
conduction abnormalities de!nition and compared with log-rank
tests. Cox proportional-hazards regression stepwise model was used
to determine whether ECG strain and conduction abnormalities were
associated with ME after adjusting for potential confounding variables.
Variables with a value of p b 0.10 on univariable analysis were incorpo-
rated into the multivariable model. A p value b0.05 was considered sta-
tistically signi!cant. Unless speci!ed, statistics were performed using
MedCalc v16.4 (Olstead, Belgium).
3. Results
3.1. Pre-operative ECGmarkers of ventricular myocardial damage in severe
symptomatic AS
A total of 1122 consecutive patients referred for AVRwere included.
Mean age was 73± 11 years. The population was made of 56% of male,
one fourth had diabetes and the large majority (91%) was symptomatic
(New York Heart Association (NYHA) class !2). The mean LV ejection
fraction (EF) was 59± 10% and 78% underwent surgical aortic valve re-
placement (SAVR). ECG strain pattern was found in 236 patients (21%)
and conduction abnormalities in 152 patients (13.5%). Characteristics of
the population according to pre-operative ECG patterns are summa-
rized in Table 1. A study "ow chart is given in Supplemental Fig. 1.
Patients with ECG !brosis/damage hallmarks were older, more fre-
quentlymen,withmore severe symptoms (NYHA stage), withmore ad-
vancedmyocardial disease as re"ected by higher LVmass index (LVMi),
larger left atrium area together with lower LVEF, global longitudinal
strain global (GLS) (respectively "14.8 ± 4.6 and "13.8 ± 4.1 vs.
"16.6 ± 4.4%, p = 0.003) and IBS (respectively "21.3 ± 11.0 and
"21.4 ± 11.0 vs. "28.6 ± 7.9 dB, p = 0.02) (Fig. 1 & Supplemental
Fig. 2). Accordingly, patients with ECG strain displayed a higher preva-
lence of ECG LVH assessed by Romhilt-Estes score (72 vs. 20%,
p b 0.0001) or Sokolow-Lyon index (19 vs. 3%, p b 0.0001). Atrial !bril-
lation and concomitant coronary artery bypass graft surgery were re-
spectively present in 10% and 20% of the population with a similar
prevalence in the 3 groups.
3.2. Prognostic impact of pre-operative ECGmarkers of ventricularmyocar-
dial damage
The mean follow-up was 4.4 ± 1.5 years. ME occurred in 212 pa-
tients (18.9%) with 113 cardiovascular deaths (10%), 89 cardiac hospi-
talizations for acute heart failure (8.0%) and 54 strokes (4.8%). All-
cause deaths occurred in 257 patients (23.0%).
Both pre-operative ECG strain and conduction abnormalities were
signi!cantly associated with increase occurrence of ME in comparison
with patients free from ECG strain, respectively (HR (95% con!dence in-
terval, CI): 1.56 (1.13–2.14), p=0.006, and 1.47 (1.02–2.13), p=0.04)
(Fig. 2A). While conduction abnormalities were signi!cantly associated
with both cardiovascular death and all-cause mortality, HR (95% CI) re-
spectively: 2.31 (1.49–3.6), p=0.0002 and 1.49 (1.08–2.07), p=0.015,
ECG strainwas not (HR (95% CI) respectively: 1.27 (0.79–2.04), p=0.29
and 1.10 (0.85–1.58), p = 0.34) (Fig. 2B, C and Supplemental Fig. 3).
On Cox univariable analysis, the occurrence of ME at 1500 days was
signi!cantly associated with old age, diabetes, hypertension, stroke,
NYHA class, low pre-operative LVEF and mean aortic gradient, atrial !-
brillation and the two ECG hallmarks of LV myocardial damage
(Table 2). After multivariable adjustment using Cox regression analysis
Table 1
Patients' characteristics according to pre-operative ECG (n = 1122).
All population (n = 1122) No ECG strain (n = 734) ECG strain (n = 236) Conduction abnormalities (n = 152) p-Value
Pre-operative data
Age (years) 72.9 ± 10.7 72.8 ± 10.7 71.1 ± 11.2 76.5 ± 9.3!,# b0.001
Gender male n (%) 628 (56.0) 384 (51.5) 161 (68.2) 83 (54.6) 0.0001
BMI (kg/m2)
Smoker n (%) 234 (20.9) 144 (19.6) 65 (27.5) 25 (16.4) 0.009
Diabetes mellitus n (%) 306 (27.3) 203 (27.7) 68 (28.8) 35 (23.0) 0.42
Hypertension n (%) 729 (65.0) 481 (65.5) 151 (64.0) 97 (63.8) 0.86
Stroke n (%) 83 (7.4) 45 (6.1) 22 (9.3) 16 (10.5) 0.08
PAD n (%) 108 (9.6) 71 (9.7) 23 (9.8) 14 (9.2) 0.85
CAD n (%) 229 (20.4) 140 (19.1) 62 (26.3) 27 (17.8) 0.38
NYHA n (%) 0.0008
1 97 (8.6) 72 (9.8) 17 (7.2) 8 (5.3)
2 631 (56.2) 419 (57.1) 130 (55.1) 82 (53.9)
3 317 (28.3) 211 (28.7) 59 (25.0) 47 (30.9)
4 77 (6.9) 32 (4.4) 30 (12.7) 15 (9.9)
TTE data
LVEF (%) 59.1 ± 9.6 60.3 ± 8.4 56.2 ± 12.1! 58.8 ± 9.9! b0.001
Max aortic velocity (m/s) 4.40 ± 0.68 4.4 ± 0.6 4.5 ± 0.8 4.3 ± 0.6 0.07
Mean gradient (mmHg) 50.6 ± 13.3 50.7 ± 12.3 52.6 ± 15.7! 50.1 ± 13.5 0.035
LVMi (g/m2) 117.9 ± 33.0 111.7 ± 29.8 130.8 ± 36.4! 127.9 ± 33.4! b0.001
LA surface (cm2) 25.8 ± 7.9 24.9 ± 8.0 27.1 ± 8.2! 28.2 ± 5.7! 0.004
ECG data
Atrial !brillation n (%) 118 (10.5) 84 (11.4) 18 (7.6) 16 (10.5) 0.25
LVH Romhlit-Estes n (%) 319 (28.4) 149 (20.3) 170 (72.0) – b0.0001
LVH Sokolow-Lyon n (%) 69 (6.1) 25 (3.4) 44 (18.6) – b0.0001
Operative data
SAVR n (%) 848 (78.3) 549 (74.8) 163 (69.1) 106 (69.7) 0.0019
Concomitant CABG n (%) 219 (19.5) 148 (20.2) 47 (19.9) 24 (15.8) 0.51
BMI: BodyMass Index; CAD: CoronaryArtery Disease; LA: Left Atrium; LVEF: Left Ventricular Ejection Fraction; LVH: Left Ventricular Hypertrophy; LVMi: Left VentricleMass index; NYHA:
New York Heart Association; PAD: Peripheral Artery Disease; SAVR: Surgical Aortic Valve Replacement.
p-Value by one-way anova analysis of variance with Bonferroni post hoc paired t-test.
Bold values indicates statistically signi!cance at pb0.05.
! For p b 0.05 by post-hoc t-test vs no ECG strain.
# For p b 0.05 by post-hoc t-test vs ECG strain.
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with stepwise selection of variables, old age, diabetes, high NYHA class,
low LVEF and the presence of ECG strainwere independently associated
with long-term occurrence of ME (p=0.44 and Chi-squared= 7.98 by
Hosmer-Lemeshow test). ECG strain was predictive of ME indepen-
dently of the type of AVR (HR: 1.40 (1.02–1.92); p = 0.03). Intra-
ventricular conduction abnormalities were not retained in the model.
4. Discussion
Exploring the clinical impact of pre-operative ECG markers of ven-
tricular myocardial damage in a large cohort of patients with severe
AS undergoing AVR, we demonstrated that ECG strain and conduction
abnormalities were frequent, i.e. respectively in 21% and 13.5% of pa-
tients. This was consistent with previous studies reporting prevalence
of 14 to 31% of this ECG features. [11–13]. Importantly, both ECG strain
and conduction abnormalities were associated with long-term cardiac
major events with conduction abnormalities also associated with all-
cause and cardiovascular deaths. The presence of pre-operative ECG
strain was independently associated with long-term occurrence of ME
together the commonly reported factors of poor prognosis after AVR,
i.e. old age, diabetes, high NYHA class and low LVEF [22,23].
To date, AVR is recommended in patients with severe AS and symp-
toms or with a LVEF b50% [1,2]. However, recent studies by Lancellotti
et al. [22] and Tribouilloy et al. [23] demonstrated that patients with a
LVEF respectively b60% and b55% are associated with an increased
morbi-mortality even after AVR, suggesting that early (surgical or trans-
catheter) AVR should be considered to avoid irreversible myocardial
damages. There is therefore a growing interest in studying the myocar-
dial consequences of this valvular heart disease. We proposed here the
simple ECG as an easy but ef!cient tool to improve multi-parametric
risk strati!cation of patients prior to AVR, and thus re!ning the optimal
timing of AVR by focusing on the myocardial repercussion of AS.
Although its physiopathology remains debated, previous studies
showed that ECG strain is associatedwith an advanced hypertrophic re-
sponse to AS with mid-wall !brosis [12]. Accordingly, we showed that
patients with ECG hallmarks of myocardial damage were older, more
frequently men, with more severe symptoms, lower LVEF, higher
LVMi and larger left atrium area.Moreover, in linewith studies identify-
ing GLS and IBS as tools to detect increased myocardial !brosis [17,23],
these 2 parameters exploring the LV were signi!cantly depressed in AS
patients with BBB or ECG strain pattern.
In addition of being amarker of a more advanced disease, ECG strain
was independently associated with poor outcomes, corroborating re-
cent !ndings by Magne et al. [13].
Based on our!ndings,multiparametric strati!cation of patientswith
severe AS prior to AVR should integrate hallmarks of ventricular myo-
cardial damage. BBB or ECG strain pattern should encourage consider-
ation for early intervention at the time of low peri-operative morbi-
mortality associated with both surgical and trans-catheter AVR.
4.1. Limitations
Assessment of myocardial !brosis was restricted to TTE parameters
since cardiac magnetic resonance (MRI) was not used routinely in our
hospital in this population. The relative prognostic insights of MRI hall-
marks of ventricle damage on top of the widely available ECG and TTE
should be tested in future studies. We sought to investigate preopera-
tive ECG markers, and not postoperative results of AVR (surgical or
transcatheter), in order to help the preoperative multiparametric stag-
ing of cardiac damage to guide AVR. Accordingly, we decided not to in-
clude peri-operative and post-operative characteristics in the survival
model.
4.2. Clinical perspectives
ECG is a reliable andwidespread tool to easily identify a subgroup of
patients with extensive anatomical and functional cardiac damage sec-
ondary to AS that translate into higher incidence of cardiac events after
Fig. 2. Kaplan-Meier Survival Curves. Long-Term prognostic impact of pre-operative ECG
markers of ventricular myocardial damage. Event-free survival from A) Major Events
(cardiovascular death, stroke or acute heart failure), B) Cardiovascular Deaths and C) All
Cause Deaths, according to pre-operative ECG. p-Value by log-rank test.
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AVR. It should help the multiparametric staging of cardiac damage to
guide AVR.
5. Conclusion
BBB or ECG strain is observed in a third of AS patients referred for
AVR. These ECG markers of myocardial damage identify a subgroup of
patients with extensive anatomical and functional cardiac damage sec-
ondary to AS that translate into higher incidence of cardiac events after
AVR.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ijcard.2020.01.073.
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Hypertension n (%) 0.04 1.37 (1.02–1.83) – – –
Stroke n (%) 0.05 1.57 (1.00–2.47) – – –
NYHA n (%) b0.0001 1.77 (1.48–2.13) 0.037 1.23 (1.01–1.50)
LVEF (%) b0.0001 !0.03 ± 0.007 – –
Mean aortic gradient (mmHg) 0.01 !0.01 ± 0.006 – –
LVMi (g/m2) 0.12 0.004 ± 0.002
Atrial !brillation n (%) 0.0001 1.87 (1.45–2.95) 0.02 1.54 (1.07–2.23)
LVH Romhilt-Estes n (%) 0.22 1.21 (0.89–1.65)
LVH Solow-Lyon n (%) 0.23 0.72 (0.53–1.16)
ECG signs of !brosis n (%)
ECG strain 0.006 1.56 (1.13–2.14) 0.03 1.40 (1.02–1.92)
Conduction abnormalities 0.04 1.47 (1.01–2.13) – – –
SAVR n (%) b0.0001 0,29 (0,22–0,38) b0.0001 0,44 (0,31–0,62)
BMI: BodyMass Index; CAD: CoronaryArtery Disease; LA: Left Atrium; LVEF: Left Ventricular Ejection Fraction; LVH: Left Ventricular Hypertrophy; LVMi: Left VentricleMass index; NYHA:
New York Heart Association; PAD: Peripheral Artery Disease; SAVR: Surgical Aortic Valve Replacement.
Bold values indicates statistically signi!cance at pb0.05.
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